Walmart Raises Prices On Diabetes Meds As Diabetes Diagnosis Rate Doubles

Looking to draw more customers to its generic medications programs and then into its stores, Walmart has raised prices by 32 percent on the 10 most-prescribed diabetes medications within the past two years, a new study says. Since Walmart began its “loss leader” strategy back in 2006 with its $4-a-month prescription offer, the pharmaceutical industry has seen a 58 percent decrease in medication costs for generic brands. The dramatic increase in brand-name medication prices coincides with the more-than-100-percent increase in the number of diabetes cases worldwide since 1980. —Sarah Bufkin